About This Resource SaniSure · June 2026

Three Engineering Disciplines That Make Reliability a Designed-In Property of Single-Use Bioprocessing Assemblies

Single-use assemblies were once evaluated primarily on cost and convenience. That calculus has changed. As biomanufacturing pipelines grow more complex — encompassing mRNA vaccines, viral vectors, and cell and gene therapies alongside traditional monoclonal antibodies — a batch loss or process failure traced to a misfit connector carries the same consequence as an equipment breakdown. This white paper examines how custom assembly design, vertical integration, and regulatory alignment converge to make reliability an engineered property, not a verified one.

Biopharmaceutical manufacturers and CDMOs evaluating single-use fluid management platforms face a set of technical and regulatory questions that go beyond material compatibility and lead time. When the supply model introduces its own variability through disconnected vendor relationships, generic documentation, or post-manufacture verification, the assembly becomes a source of process risk rather than a controlled component of it.

SaniSure Custom Assembly Platform Validated component library · Vertical integration across Americas and EMEA · Annex 1 and USP<665> aligned
What the white paper covers
  • How validated component libraries enable configuration changes without triggering component-level requalification, and what that means for process-specific customization at scale
  • Why vertical integration eliminates the principal sources of inter-vendor dimensional variability, and how lot-linked traceability simplifies risk assessments under ICH Q9(R1)
  • How assembly-level design choices propagate directly into PUPSIT and EU GMP Annex 1 outcomes, including pull-force, burst, and pressure-decay testing per connection point
  • The shift from BPOG solvent-extraction frameworks to USP<665> and USP<1665>, and what specificity at the resin-lot level demands from suppliers
  • A reference model for how all three disciplines operate within a single supply relationship, drawing on SaniSure’s custom assembly and fluid management platform
3 Engineering disciplines that shift reliability from a post-manufacture finding to a designed-in property
2022 EU GMP Annex 1 update requiring every sterile fluid path connection point to be assessed within a facility-wide CCS
2 Manufacturing regions — Americas and EMEA — covered by SaniSure’s dual-site supply continuity model referenced in the paper
Key findings
01
Configure Without Triggering Requalification

A qualified library of tubing formulations, molded connectors, closures, and filter interfaces allows engineers to adjust tubing length, connector geometry, dip-tube orientation, or filter staging without triggering component-level requalification. Assemblies developed at 20-liter scale transfer to 200-liter GMP operations with identical documentation and qualification data.

Validated component library
02
Traceability as a Supply Chain Property

End-to-end manufacturing control within a single quality system ensures extractables data link directly to the specific resin, processing conditions, and sterilization cycle associated with each assembly. Dimensional tolerances are validated against actual connector geometries. Certificates of Conformance are unified rather than assembled from multiple vendor packages.

Vertical integration
03
PUPSIT and Annex 1 Alignment from the Assembly Up

EU GMP Annex 1 (2022) requires every connection point in a sterile fluid path to be assessed and documented within a facility-wide contamination control strategy. PUPSIT exposes how assembly design choices propagate directly into regulatory outcomes. Pull-force, burst, and pressure-decay testing per connection point addresses this systematically at the design stage.

Annex 1 aligned
04
USP<665> Extractables Data Linked to Resin Lots

The shift from legacy BPOG frameworks to USP<665> and USP<1665> has raised the bar for specificity. Suppliers who provide extractables data linked to specific resin lots and processing parameters significantly reduce leachables risk assessment burden for end-users, both at IND submission and during commercial process validation.

USP<665> aligned

This white paper is written for process engineers, QA managers, and regulatory affairs teams at biopharmaceutical manufacturers and CDMOs evaluating single-use fluid management platforms or preparing for Annex 1 audits and USP<665> submissions. The full analysis and supporting references are in the PDF download.

Free Download

Download the White Paper

Complete the form for access to the full Reliability by Design white paper, including analysis of all three engineering disciplines and their regulatory implications.

SaniSure · June 2026
Reliability by Design
White Paper  /  PDF
  • How validated component libraries enable customization without requalification at every scale
  • Why vertical integration eliminates inter-vendor variability and simplifies ICH Q9(R1) risk assessments
  • How assembly-level design choices propagate into PUPSIT results and EU GMP Annex 1 outcomes
  • The shift from BPOG extractables frameworks to USP<665> and what it demands from suppliers
  • A reference model drawing on SaniSure’s custom assembly and fluid management platform